This inventor holds 7 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignee: Novagen Holding Corporation. Active years: 2009-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Vancouver, CA (2009 - 2013)
- Surrey, CA (2016 - 2020)
Company Filing History:
Years Active: 2009-2020
Title: Innovations of Ling Wang in Recombinant Human Interferon-like Proteins
Introduction
Ling Wang is a notable inventor based in Vancouver, Canada, recognized for his contributions to the field of biotechnology. He holds a total of seven patents, focusing primarily on recombinant human interferon-like proteins. His work has significant implications for the treatment of viral diseases and cancer.
Latest Patents
Ling Wang's latest patents include a method of treating diseases with recombinant human interferon-like proteins. This application describes a recombinant protein created by gene shuffling technology, which exhibits enhanced anti-viral and anti-proliferative activities compared to naturally occurring human interferon-like alpha 2 (HuIFN-α2). The invention encompasses a polynucleotide encoding the protein and recombinant vectors and host cells that comprise the polynucleotide. The polynucleotide is preferably selected from a group of polynucleotides each having a sequence at least 93% identical to SEQ ID: No. 1, while the protein is selected from a group of proteins each having an amino acid sequence at least 85% identical to SEQ ID No: 2. These proteins and compositions can be utilized for treating conditions responsive to interferon therapy, such as viral diseases and cancer.
Career Highlights
Ling Wang is currently associated with Novagen Holding Corporation, where he continues to innovate in the field of biotechnology. His research and inventions have contributed to advancements in therapeutic methods, particularly in the treatment of diseases that require interferon therapy.
Collaborations
Ling Wang has collaborated with notable colleagues, including Haitao Wang and Jizhi Li, who have contributed to his research endeavors.
Conclusion
Ling Wang's innovative work in recombinant human interferon-like proteins showcases his commitment to advancing medical treatments. His patents reflect a significant contribution to biotechnology, particularly in addressing viral diseases and cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile